Dimensional Fund Advisors LP Vir Biotechnology, Inc. Transaction History

Dimensional Fund Advisors LP

  • $391 Billion
  • Q1 2025

A detailed history of Dimensional Fund Advisors LP transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,684,415 shares of VIR stock, worth $12.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,684,415
Previous 1,915,465 40.14%
Holding current value
$12.2 Million
Previous $14.1 Million 23.73%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$6.48 - $12.48 $4.98 Million - $9.6 Million
768,950 Added 40.14%
2,684,415 $17.4 Million
Q4 2024

Feb 13, 2025
BUY
$6.74 - $10.17 $4.74 Million - $7.15 Million
703,360 Added 58.03%
1,915,465 $14.1 Million
Q3 2024

Nov 07, 2024
BUY
$7.26 - $10.7 $4.17 Million - $6.15 Million
574,619 Added 90.14%
1,212,105 $9.08 Million
Q2 2024

Aug 09, 2024
BUY
$7.63 - $12.66 $445,286 - $738,837
58,360 Added 10.08%
637,486 $5.67 Million
Q1 2024

May 10, 2024
BUY
$8.6 - $11.9 $952,940 - $1.32 Million
110,807 Added 23.66%
579,126 $5.87 Million
Q4 2023

Feb 07, 2024
SELL
$7.76 - $10.29 $2.01 Million - $2.67 Million
-259,296 Reduced 35.64%
468,319 $4.71 Million
Q3 2023

Nov 09, 2023
SELL
$9.14 - $24.62 $2.7 Million - $7.27 Million
-295,124 Reduced 28.86%
727,615 $6.82 Million
Q2 2023

Aug 09, 2023
BUY
$23.2 - $27.29 $22.7 Million - $26.7 Million
977,639 Added 2167.71%
1,022,739 $25.1 Million
Q3 2022

Nov 10, 2022
SELL
$18.26 - $31.1 $1.32 Million - $2.25 Million
-72,279 Reduced 61.58%
45,100 $870,000
Q2 2022

Aug 12, 2022
SELL
$19.08 - $26.7 $9.44 Million - $13.2 Million
-494,957 Reduced 80.83%
117,379 $2.99 Million
Q1 2022

May 13, 2022
BUY
$21.19 - $40.01 $6.18 Million - $11.7 Million
291,785 Added 91.03%
612,336 $15.7 Million
Q4 2021

Feb 09, 2022
BUY
$30.97 - $54.03 $8.33 Million - $14.5 Million
269,069 Added 522.65%
320,551 $13.4 Million
Q3 2021

Nov 12, 2021
BUY
$34.9 - $54.54 $481,375 - $752,270
13,793 Added 36.6%
51,482 $2.24 Million
Q2 2021

Aug 12, 2021
SELL
$38.75 - $51.0 $402,263 - $529,431
-10,381 Reduced 21.6%
37,689 $1.78 Million
Q1 2021

May 14, 2021
BUY
$26.34 - $83.07 $1.01 Million - $3.17 Million
38,200 Added 387.03%
48,070 $2.47 Million
Q4 2020

Feb 25, 2021
BUY
$25.51 - $43.38 $251,783 - $428,160
9,870 New
9,870 $264,000

Others Institutions Holding VIR

# of Institutions
251
Shares Held
91.5M
Call Options Held
257K
Put Options Held
261K
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $604M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email